-
EP4175971
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4175971
| EP4175971 - STABILIZED CORONA VIRUS SPIKE PROTEIN FUSION PROTEINS [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 09.05.2025 Database last updated on 09.04.2026 | |
| Former | Request for examination was made Status updated on 07.04.2023 | ||
| Former | The international publication has been made Status updated on 14.01.2022 | ||
| Former | unknown Status updated on 04.08.2021 | Most recent event Tooltip | 09.05.2025 | Application deemed to be withdrawn | published on 11.06.2025 [2025/24] | Applicant(s) | For all designated states Janssen Pharmaceuticals, Inc. 1125 Trenton-Harbourton Road Titusville, NJ 08560 / US | [2023/19] | Inventor(s) | 01 /
LANGEDIJK, Johannes, Petrus, Maria 2333 CN Leiden / NL | 02 /
RUTTEN, Lucy 2333 CN Leiden / NL | 03 /
JURASZEK, Jaroslaw 2333 CN Leiden / NL | [2023/19] | Representative(s) | van Wanrooij, Eva Janssen Vaccines & Prevention B.V. IP Department Archimedesweg 4-6 2333 CN Leiden / NL | [N/P] |
| Former [2023/19] | Manten, Annemieke, et al Janssen Vaccines & Prevention B.V. Archimedesweg 4-6 2333 CN Leiden / NL | Application number, filing date | 21745927.0 | 05.07.2021 | [2023/19] | WO2021EP68505 | Priority number, date | US202062705584P | 06.07.2020 Original published format: US 202062705584 P | [2023/19] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2022008438 | Date: | 13.01.2022 | Language: | EN | [2022/02] | Type: | A1 Application with search report | No.: | EP4175971 | Date: | 10.05.2023 | Language: | EN | The application published by WIPO in one of the EPO official languages on 13.01.2022 takes the place of the publication of the European patent application. | [2023/19] | Search report(s) | International search report - published on: | EP | 13.01.2022 | Classification | IPC: | C07K14/005, C07K14/165, A61K39/12 | [2023/19] | CPC: |
C07K14/005 (EP,IL,KR);
A61K39/215 (KR,US);
A61K39/12 (EP,IL);
A61P31/14 (KR);
C12N15/62 (KR);
C12N15/86 (KR,US);
A61K2039/53 (US);
C07K2319/00 (KR);
C12N2710/10343 (KR,US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2023/19] | Title | German: | STABILISIERTE CORONAVIRUS-SPIKE-PROTEIN-FUSIONSPROTEINE | [2023/19] | English: | STABILIZED CORONA VIRUS SPIKE PROTEIN FUSION PROTEINS | [2023/19] | French: | PROTÉINES DE SPICULE DE CORONAVIRUS STABILISÉES À TITRE DE PROTÉINES DE FUSION | [2023/19] | Entry into regional phase | 23.01.2023 | National basic fee paid | 23.01.2023 | Designation fee(s) paid | 23.01.2023 | Examination fee paid | Examination procedure | 23.01.2023 | Examination requested [2023/19] | 23.01.2023 | Date on which the examining division has become responsible | 04.08.2023 | Amendment by applicant (claims and/or description) | 01.02.2025 | Application deemed to be withdrawn, date of legal effect [2025/24] | 17.02.2025 | Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time [2025/24] | Fees paid | Renewal fee | 14.06.2023 | Renewal fee patent year 03 | Penalty fee | Additional fee for renewal fee | 31.07.2024 | 04 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [AP] US2020407402 (HE LINLING et al.) | [I] HOFFMANN MARKUS ET AL: "SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.", CELL 16 04 2020, vol. 181, no. 2, 16 April 2020 (2020-04-16), pages 271 - 280.e8, XP086136225, ISSN: 1097-4172 DOI: http://dx.doi.org/10.1016/j.cell.2020.02.052 | [AP] JURASZEK JAREK ET AL: "Abstract", NATURE COMMUNICATIONS, vol. 12, no. 1, 1 January 2021 (2021-01-01), XP055827254, Retrieved from the Internet DOI: http://dx.doi.org/10.1038/s41467-020-20321-x | by applicant | WO2017037196 | WO9609378 | US6083716 | WO2005071093 | WO2010086189 | WO2010085984 | WO2012172277 | WO2018215766 | WO2019086466 | WO2019086456 | WO2006040330 | WO2019086461 | WO03104467 | WO2007104792 | WO2012082918 | US5385839 | US5122458 | WO9014837 | US5057540 | WO9003184 | WO9611711 | WO2004004762 | WO2005002620 | US4235877 | US4372945 | US4474757 | FARINA ET AL., J VIROL, vol. 75, 2001, pages 11603 - 13 | COHEN ET AL., J GEN VIROL, vol. 83, 2002, pages 151 - 55 | KOBINGER ET AL., VIROLOGY, vol. 350, 2006, pages 358 - 401 | TATSIS ET AL., MOLECULAR THERAPY, vol. 15, 2007, pages 608 - 17 | BANGARIMITTAL, VACCINE, vol. 24, 2006, pages 849 - 62 | LASAROERTL, MOL THER, vol. 17, 2009, pages 1333 - 39 | HAVENGA ET AL., J GEN VIROL, vol. 87, 2006, pages 2135 - 43 | ABBINK ET AL., VIROL, vol. 81, no. 9, 2007, pages 4654 - 63 | "GenBank", Database accession no. EF 153474 | ABBINK, J VIROL, vol. 81, no. 9, 2007, pages 4654 - 63 | "Tissue Culture", 1973, ACADEMIC PRESS | R.I. FRESHNEY: "Pharmaceutical Formulation Development of Peptides and Proteins", 2000, PHARMACEUTICAL PRESS | "Remington's Pharmaceutical Sciences", 1990, MACK PUBLISHING COMPANY | WRAPP, SCIENCE, vol. 367, no. 6482, 2020, pages 1260 - 1263 | BELOUZARD ET AL., PROC NATL ACAD SCI U S A, vol. 106, 2009, pages 5871 - 6 | BOSCH ET AL., J VIROL, vol. 82, 2008, pages 8887 - 90 | MADU ET AL., J VIROL, vol. 83, 2009, pages 7411 - 21 | WALLS ET AL., NATURE, vol. 531, 2016, pages 114 - 7 | HOFFMANN ET AL., BIORXIV, 2020 | HASTIE ET AL., SCIENCE, vol. 356, 2017, pages 923 - 928 | KRARUP ET AL., NAT COMMUN, vol. 6, 2015, pages 8143 | PALLESEN ET AL., PROC NATL ACAD SCI USA, vol. 114, 2017, pages E7348 - E7357 | RUTTEN ET AL., CELL REP., vol. 30, no. 13, 2020, pages 4540 - 4550 | LETAROV ET AL., BIOCHEMISTRY MOSCOW, vol. 64, 1993, pages 817 - 823 | S-GUTHE ET AL., J. MOL. BIOL., vol. 337, 2004, pages 905 - 915 |